Skip to main content

Web Exclusives

FDA Approvals, In the News
FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma
Read More
FDA Approvals, In the News
February 1, 2019 - FDA Approvals, News & Updates
Read More
FDA Approvals, In the News
Government Shutdown Impacts FDA Drug Approvals
Read More
FDA Approvals
A “Gold Standard” for Population Health? Revisiting the FDA’s Relationship with the Hippocratic Oath
Read More
Press Releases, Original Research
Researchers Identify 4 Predictors of Transition to Chronic Opioid Use Based on Readily Available Opioid Regimen and Patient Factors
Read More
Press Releases
Access Market Intelligence Introduces Online Glossary of Common Drug Related Terms and Acronyms as e-Book
Read More
FDA Approvals
First FDA-Approved Test to Help Detect Several Leukemias and Lymphomas
Read More
FDA Approvals
First CAR T-Cell Therapy Unanimously Recommended by FDA Advisory Committee for Treatment of B-Cell ALL in Children and Young Adults
Read More
FDA Approvals, In the News
Rituximab Combination Now Approved in 3 Blood Cancers
Read More
FDA Approvals
Darzalex Combined with Pomalidomide and Dexamethasone Approved for Relapsed/Refractory Multiple Myeloma
Read More
Page 21 of 37
Results 201 - 210 of 364